» Articles » PMID: 35430622

A Comprehensive Analysis of Excess Depressive Disorder in Women and Men Living with HIV in France compared to the General Population

Abstract

We aimed to estimate the prevalence of depressive disorder in people living with HIV (PLWH) and evaluate its association with non-HIV-specific and HIV-specific factors in PLWH and in PLWH compared to the general population (GP). We used cross-sectional data from the QuAliV study, conducted within the ANRS-CO3 Aquitaine-AQUIVIH-NA cohort of PLWH in Nouvelle-Aquitaine (2018-2020), and a nationally-representative survey in the GP (EHIS-ESPS, 2014-2015), we included all participants aged ≥ 18 years old who had completed the Patient Health Questionnaire-8 (PHQ-8). Depressive disorder was defined as Patient Health Questionnaire-8 score greater or equal to 10. Its association with non-HIV-specific (demographic, socio-economic, behavioral, health status), HIV-specific factors (immuno-viral markers, antiretrovirals, level of perceived HIV-stigma), and HIV-status was assessed using Poisson regression models with robust variance in women and men separately. We included 914 PLWH (683 men/231 women). More than one in five PLWH had depressive disorder. It was strongly associated with being younger and experiencing severe pain in both sexes. Unemployment in women, being single, and lack of family ties in men were also associated with depressive disorder. More than 30% of our sample reported HIV-stigma, with a dose-response relationship between level of perceived HIV-stigma and depressive disorder. The crude prevalence of depressive disorder was 2.49 (95%CI 1.92-3.22) and 4.20 (95%CI 3.48-5.05) times higher in women and men living with HIV respectively compared to GP counterparts and 1.46 (95%CI 1.09-1.95) and 2.45 (95%CI 1.93-3.09) times higher after adjustment for non-HIV specific factors. The adjusted prevalence ratio of depressive disorder was not significantly different in HIV-stigma free women, but remained twice as high in HIV-stigma free men. The prevalence of depressive disorder compared to the GP tended to decrease with age in PLWH. Excess depressive disorder remains a major concern in PLWH. Our findings reaffirm the importance of regular screening. Tackling social inequalities and HIV-stigma should be prioritized to ensure that PLWH achieve good mental as well as physical health outcomes.

Citing Articles

Pain intensity and comorbid depressive symptoms in the general population: An analysis of the German Health Update Study (GEDA 2019/2020-EHIS).

Ahrend J, Jobski K, Bantel C, Hoffmann F Eur J Pain. 2024; 29(3):e4745.

PMID: 39444226 PMC: 11755701. DOI: 10.1002/ejp.4745.


The impact of the COVID-19 pandemic on mental health care utilization among people living with HIV: A real-world data study.

Pasha A, Qiao S, Zhang J, Cai R, He B, Yang X medRxiv. 2024; .

PMID: 39398989 PMC: 11469454. DOI: 10.1101/2024.09.26.24314443.


Factors Related to Prevalence of Depression in Türkiye: A Population-Based Study.

Yildiz N, Aydin K, Aydin H, Phiri Y, Yildiz H Turk Psikiyatri Derg. 2024; 35(3):167-177.

PMID: 39224989 PMC: 11375740. DOI: 10.5080/u27179.


Prevalence of Mental Health Disorders and Their Associated Risk Factors Among People Living with HIV in Rwanda: A Cross-Sectional Study.

Omann L, Dushimiyimana V, Musoni-Rwililiza E, Arnbjerg C, Niyonkuru V, Iyamuremye J AIDS Behav. 2024; 28(8):2666-2682.

PMID: 38736005 PMC: 11286631. DOI: 10.1007/s10461-024-04358-3.


Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study).

Barger D, Hessamfar M, Neau D, Farbos S, Leleux O, Cazanave C Sci Rep. 2023; 13(1):16535.

PMID: 37783722 PMC: 10545822. DOI: 10.1038/s41598-023-43434-x.


References
1.
Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S . Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807. PMC: 4569751. DOI: 10.1056/NEJMoa1506816. View

2.
Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L . Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016; 6(7):e011453. PMC: 4947735. DOI: 10.1136/bmjopen-2016-011453. View

3.
Lazarus J, Safreed-Harmon K, Barton S, Costagliola D, Dedes N, Del Amo Valero J . Beyond viral suppression of HIV - the new quality of life frontier. BMC Med. 2016; 14(1):94. PMC: 4916540. DOI: 10.1186/s12916-016-0640-4. View

4.
Turan B, Hatcher A, Weiser S, Johnson M, Rice W, Turan J . Framing Mechanisms Linking HIV-Related Stigma, Adherence to Treatment, and Health Outcomes. Am J Public Health. 2017; 107(6):863-869. PMC: 5425866. DOI: 10.2105/AJPH.2017.303744. View

5.
Feuillet P, Hamelin C, Spire B, Dray-Spira R, Lert F . Intimate ties of people living with HIV in France resulted both from social status and the experience of being HIV-infected: results from the ANRS-Vespa2 study, France. AIDS Care. 2017; 30(7):807-816. DOI: 10.1080/09540121.2017.1420136. View